194 related articles for article (PubMed ID: 19711435)
1. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of detection of CD99
Zakzok O; Elshanshory M; Zekri W; Elsharkawy N; Zaky I; Salama A; Kamel A; Elantably I; Said S
Pediatr Blood Cancer; 2022 Jan; 69(1):e29298. PubMed ID: 34403190
[TBL] [Abstract][Full Text] [Related]
3. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
Vo KT; Edwards JV; Epling CL; Sinclair E; Hawkins DS; Grier HE; Janeway KA; Barnette P; McIlvaine E; Krailo MD; Barkauskas DA; Matthay KK; Womer RB; Gorlick RG; Lessnick SL; Mackall CL; DuBois SG
Clin Cancer Res; 2016 Jul; 22(14):3643-50. PubMed ID: 26861456
[TBL] [Abstract][Full Text] [Related]
4. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
[TBL] [Abstract][Full Text] [Related]
5. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
[TBL] [Abstract][Full Text] [Related]
8. [Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor].
Liu BY; Yang Y; DU J; Zhang Y; Wang H; Zheng J
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):358-62. PubMed ID: 18677380
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens.
Fernandez-Pol S; van de Rijn M; Natkunam Y; Charville GW
Virchows Arch; 2018 Dec; 473(6):765-769. PubMed ID: 30014288
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis.
Bühnemann C; Li S; Yu H; Branford White H; Schäfer KL; Llombart-Bosch A; Machado I; Picci P; Hogendoorn PC; Athanasou NA; Noble JA; Hassan AB
PLoS One; 2014; 9(9):e107105. PubMed ID: 25243408
[TBL] [Abstract][Full Text] [Related]
11. Primary orbital Ewing sarcoma in a middle-aged woman.
Choi RY; Lucarelli MJ; Imesch PD; Hafez GR; Albert DM; Dortzbach RK
Arch Ophthalmol; 1999 Apr; 117(4):535-7. PubMed ID: 10206587
[TBL] [Abstract][Full Text] [Related]
12. MIC-2 positive granulocytic sarcoma of ulna mimicking Ewing sarcoma.
Prakash G; Ganesan P; Ahuja A; Bakhshi S
Pediatr Blood Cancer; 2008 Dec; 51(6):836-7. PubMed ID: 18680149
[No Abstract] [Full Text] [Related]
13. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
[TBL] [Abstract][Full Text] [Related]
14. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
15. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
Hristozova T; Konschak R; Budach V; Tinhofer I
Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
[TBL] [Abstract][Full Text] [Related]
17. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
[TBL] [Abstract][Full Text] [Related]
18. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
[TBL] [Abstract][Full Text] [Related]
19. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
Chebib I; Jo VY
Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
